Dermatitis herpetiformis (DH) shares some clinical features and major histocompatibility complex (MHC) markers with gluten-sensitive enteropathy (GSE) . We compared MHC haplotypes in 27 patients with DH, 35 patients with GSE, and normal controls. As in GSE, the frequencies of two extended haplotypes, [HLA-B8, SC01, DR3] and [HLA-B44, FC31, DR7], were increased in patients with DH. Distributions of fragments of extended haplotypes, consisting of some but not all ofthe elements ofcomplete extended haplotypes, were analyzed to attempt to localize a susceptibility gene. Besides complete extended susceptibility haplotypes, (DR3, DQ2) and (DR7, DQ2) fragments were most common in GSE. In contrast, DH showed only a few such fragments but many instances of the fragment (SC01) . The differences in distribution of these fragments in the two diseases were highly significant (P <0.002). HLA-DQ2 and DR3 had the highest odds ratios for GSE, but the highest odds ratio for DH was for the complotype SCOL These findings suggest that the MHC susceptibility gene for DH is between class II and complotype regions, closest to the complotype, whereas that for GSE is in the class lI region . D ermatitis herpetiformis (DH)' is a chronic pruritic papulo-vesicular disease of the skin characterized by the granular deposition ofI&A in the dermal papillae and by patchy focal asymptomatic villous atrophy of the small intestine (1, 2). In Caucasian patients, there is a marked increase in HLA-B8, DR3, and DQ2 (3-7) . These genes are components of the fixed conserved extended haplotype [HLA-B8, SC01, DR31 (8) . The recent report of an increase in HLA-DPI (9) in patients with DH who carry markers of this haplotype may be secondary to their known linkage disequilibrium in general (10, 11) . A less striking increase in HLA-Dw7 in DH patients has also been reported (12). The same HLA markers have been noted to be increased in celiac disease (glutensensitive enteropathy [GSE]) (13-16) . Moreover, patients with DH and GSE share a number ofother features, such asjejunal atrophy correctable by elimination of gliadin from the diet, i Abbreviations used in this paper: DH, dermatitis herpetiformis; GSE, gluten-sensitive enteropathy.
D ermatitis herpetiformis (DH)
is a chronic pruritic papulo-vesicular disease of the skin characterized by the granular deposition ofI&A in the dermal papillae and by patchy focal asymptomatic villous atrophy of the small intestine (1, 2) . In Caucasian patients, there is a marked increase in HLA-B8, DR3, and DQ2 (3-7) . These genes are components of the fixed conserved extended haplotype [HLA-B8, SC01, DR31 (8) . The recent report of an increase in HLA-DPI (9) in patients with DH who carry markers of this haplotype may be secondary to their known linkage disequilibrium in general (10, 11) . A less striking increase in HLA-Dw7 in DH patients has also been reported (12) . The same HLA markers have been noted to be increased in celiac disease (glutensensitive enteropathy [GSE] ) (13) (14) (15) (16) . Moreover, patients with DH and GSE share a number ofother features, such asjejunal atrophy correctable by elimination of gliadin from the diet, i Abbreviations used in this paper: DH, dermatitis herpetiformis; GSE, gluten-sensitive enteropathy. 2067 and the presence of anti-a-gliadin (17, 18) and antireticulin (19, 20) antibodies. We have reported family studies in GSE (21) that show that all increased available HLA markers are parts of two extended haplotypes : [HLA-B8, SC01, DR3] and [HLA-B44, FC31, DR7].
Previous studies of DH have almost exclusively reported HLA phenotypes in patients rather than haplotypes determined in family studies . Haplotype comparisons, including analysis for complotypes and other MHC genes, are critical to localizing candidate susceptibility genes, and we undertook such studies in patients with DH. We present these results in this report and compare these DH haplotypes with those derived from our earlier studies in GSE . Our results suggest that, despite the similarity of individual MHC allele markers for GSE and DH, the susceptibility genes for the two disorders are different . That for GSE appears to be in or near the HLA-DR/DQ region, whereas that for DH appears to be between complement and DR/DQ, closest to the complement region.
Materials and Methods
Samples. Blood from 27 randomly ascertained Caucasian patients with dermatitis herpetiformis and 147 of their first-degree relatives was collected into 7-ml Vacutainer tubes (Becton Dickinson & Co., Rutherford, NJ) containing 10.5 mg of potassium EDTA and into syringes containing 500-1,000 U of sodium heparin diluted with an equal volume of RPMI 1640. 25 patients were unrelated; 2 (43416 and 43417) were siblings. Lymphocytes were separated from heparinized blood by Ficoll-Hypaque centrifugation, frozen, and stored in vapor phase liquid nitrogen until thawed for HLA analysis. Plasma separated from blood anticoagulated with EDTA was stored at -80°C until just before analysis for complement types.
Patients. All patients with DH had a history of and on physical examination had evidence of typical pruritic grouped vesicles on extensor surfaces oflimb skin. The diagnosis ofDH was confirmed by the presence ofgranular deposits of IgA by direct immunofluorescence microscopy in the dermal papillae of perilesional skin (22) . 35 patients with GSE were studied, of which 24 were reported earlier (21) .
MHC Marker Studies. HLAA, B, DR, and DQ typing were by standard assays (23, 24) . Plasma samples were analyzed for genetic polymorphism in C2 (25) , in factor B (BF) (26) , and in C4 (27) by methods previously described . Complotypes are haplotypes of specific alleles of these four closely linked loci and are designated in arbitrary order by their BF, C2, C4A, and C4B alleles, including QO for null alleles (28). Thus, FC30 stands for BF*F, C2*C, C4A*3, and C4B*Q0 .
Haplotype Analysis. Alleles were assigned to haplotypes on the basis offamily studies except for sequence-specific oligonucleotidedetermined alleles, which were studied only in patients. The two DH-affected siblings were MHC haploidentical and thus contributed three independent disease haplotypes to the analysis.
Class 77 (HLA-DR, DQ and DP) Allele Typing. Genomic DNA was isolated from PBL or from EBVtransformed cell lines of 17 DH patients and 10 GSE patients. Sequence-specific oligonucleotide (SSO) probe hybridization was carried out according to the protocols of the 11th International Histocompatibility Workshop (11) . Briefly, PCR amplifications were carried out on 0.6-,ug samples of purified genomic DNA in a 100-Al reaction mixture containing 50 pmol of each primer, 50 mM KCI, 10 mM Tris-HCI, pH 8.3 , 0.2 mM of each deoxynucleotide, 2.5 U of Taq polymerase (Promega Biotec, Madison, WI), and 1.5 mM MgC12. The primers used were those recommended by the 11th Workshop. About 50 ng of amplified DNA was spotted on several nylon membranes . These were prehybridized at 54*C with hybridization buffer (50 mM Tris HCl, 3 M tetramethyl ammonium chloride, 2 mM EDTA, 0.1% SDS, 100 mg/mlheat-denatured herring sperm DNA, and 5 x Denhardt's solution) for 1 h. The allele-specific oligonucleotides labeled with y-[ 32 P]ATP were added . HLA-DRB1, -DQA1, -DQB1, and -DPB1 alleles were identified after incubation, washing, and autoradiography of the exposed membranes . Haplotype assignments were deduced from known linkage disequilibria for all loci but DPB1. The order of genes in the MHC from telomere to centromere is HLA-A, B, complotype, DR, DQ, and DP.
Statistical Analyses. Statistical significance of the differences in frequency of individual MHC alleles and extended haplotypes in the patient and control populations of haplotypes was estimated by XZ Table 1 in relation to these extended haplotypes and their fragments from telomeric to centromeric. Two haplotypes, 42453b and 43655b, had elements of both extended haplotypes and are shown in each category. The arrangement permits the easy identification of fragments of the extended haplotypes . Thus, there were 22 instances of the complete [HLA-B8, SC01, DR3] extended haplotype and 10 examples offragments ofthis haplotype. Of the fragments, there were two examples of (SC01, DR3) without B8, and single examples of B8 without SC01 or DR3, (B8, SC01) without DR3, and DR3 without SCOL In contrast, there are five cases of (SCOT) without B8 or DR3. Because HLA-DQ2, in strong linkage disequilibrium with both DR3 and DR7, was also increased markedly (see below), these findings suggest that the susceptibility gene lies between the complotype region and HLA-DR/DQ.
Of the 16 haplotypes related to [HLA-B44, FC31, DR7], there were 3 instances of the complete extended haplotype . Of the 13 cases of fragments, 5 had HLA-B44 and complotypes other than FC31, 6 had DR7 but not FC31 (2 of these had SC01), 2 had (FC31, DR7) but not HLA-B44, there was 1 instance of (FC31) alone, and 6 with (DR7, DQ2) alone. These findings are consistent with the possibility that a susceptibility gene lies in the complotype-DR/DQ region of the MHC. In keeping with these conclusions was the finding that all (27/27) patients carried SC01 or FC31 and almost all carried HLA-DQ2 (26/27) and DR3 or DR7 (26/27) .
MHC Class 17 Alleles Defined by Sequence-specific Oligonucleotide Typing. HLA-DRB1, DQA1, and DQB1 alleles are listed in Table 2 for patients with DH. In all instances, the DQA1 and DQB1 alleles present conformed to the DRB1 alleles predicted from known essentially invariable linkage disequilibria in Caucasians . Of the 27 DH patients, 21 carried the DRB1*0301, DQA1*0501, DQB1*0201 haplotype found on all HLA-DR3 haplotypes and instances of[HLA-B8, SC01, DR3]. Of the six patients who did not, three were DRBl*11, DQA1*0501, DQB1*0301/DRB1*07, DQA1*0201, DQB1*-0201 heterozygotes, and one each were heterozygotes for DRB1*0103, DQA1*0101, DQB1*0501/DRBI*07, DQAl*-0201, DQB1*0201 ; DRBl*0101, DQA1*0101, DQBl*0501/ DRB1*04, DQA1*0301, DQB1*0302, and DRB1*04, DQA1*-0301, DQBi*0302/DRBI*07, DQA1*0201, DQB1*0303 . The overall distribution ofDR specificity homozygotes and heterozygotes was not different from that predicted from the Hardy-Weinberg distribution .
The frequency of HLA-DPBl*0101 (6/28) was increased (p <0.003) among DH haplotypes compared with the freShown are all specificities assigned to haplotypes by family study.
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Comparison of MHC Haplotypes in Patients with DH with Those in Patients with GSE. Table 4 lists MHC haplotypes in 35 patients with GSE . In the two groups of patients, only HLA-A29 was higher in GSE (p = 0.012) and only HLA-DR1 was higher in DH (p = 0.018) among all alleles and extended haplotypes compared . These differences were only nominally significant and lost significance after correction for the number ofcomparisons. HLA-DRBI, DQA1, and DQB1 alleles observed among GSE patients were those predicted by known linkage disequilibria with generic DR types.
Because so many ofthe DH patient haplotypes were related to [HLA-B8, SC01, DR3], analyses of the distribution of alleles and haplotypes were carried out after the removal of the complete [HLA-B8, SC01, DR3] haplotype from all patient and control haplotypes. The increases in patients' SC01, C4A'Q0, and HLA-DQ2 remained highly significant . In addition, the increase in [HLA-B44, FC31, DR7] among DH patient haplotypes wasjust significant (compared with family
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controls but not to overall controls) at p <0. 05 . By themselves, these observations suggested that the chromosomal region between SC01 and HLA-DQ2 contains susceptibility gene(s) for DH. Odds ratios for MHC alleles and haplotypes in the DH and GSE patient and control populations with and without patients positive for the complete [HLA-B8, SC01, DR3] extended haplotype were calculated and the results are given in Table 5 . It is seen that for DH the highest odds ratio with and without the extended haplotype was that of SC01 followed by that of HLA-DQ2, whereas in GSE it was DQ2 followed by DR3 .
The distribution of fragments of [HLA-B8, SC01, DR3] among 55 DH patient haplotypes (Table 1) was compared with those among 70 GSE patient haplotypes (Table 6 ). In DH, there were six haplotypes with SC01 but not DR3 and only one haplotype with DR3 but not SC01, whereas in GSE there were no haplotypes with SC01 but not DR3 and eight haplotypes with DR3 but not SC01 (p <0.002), as shown in Table 6 .
We had earlier noted that in patients with GSE, HLA-A1 was less frequently found on [HLA-B8, SC01, DR3] than on control haplotypes (Table 4) . This phenomenon was not seen in patients with DH (Table 1) , in whom 16 of 22 in- 
Discussion

Family
Our observations strongly suggest that the major susceptibility genes within the MHC for GSE and DH are different, or at least has different locations, in spite of the fact that the two disorders share clinical features and similar MHC markers, including extended haplotypes. That for GSE appears to lie in the DR/DQ region, whereas that for DH is near the complotype region, perhaps between it and DR/DQ.
As previously reported (21), all of the HLA markers for GSE are derived from two conserved or extended haplotypes, [HLA-B8, SCO1, DR3j and [HLA-B44, FC31, DR7]. It is evident that for both HLA-DR3, DQ2-and HLA-DR7, DQ2-bearing haplotypes that (DR, DQ) fragments of the complete extended haplotypes were specifically enriched over (HLA-B, complotype), (complotype), or (complotype, DR, DQ) fragments in GSE . These findings support the concept that a gene in the DR, DQ region, probably a class II gene, is the susceptibility gene for GSE .
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Even though MHC markers among DH patient haplotypes were very similar and the same extended haplotypes were increased as in GSE, the (SC01) fragment was specifically enriched over (B8, SCO1), (SCO1, DR3, DQ2), and (DR3, DQ2). Furthermore, there was only one haplotype with DR3 but not SCOT, but six with SC01 but not DR3 . SC01 had the highest odds ratio of any MHC marker in DH, including DQ2 . All of these points support the conclusion that the DH susceptibility gene is near SCOT. This was in contrast to GSE, in which DQ2 had the highest odds ratio.
The findings with respect to DH haplotypes related to [HLA-B44, FC31, DR7] were less clear cut in that both HLA-B44 and DR7 alone were often (and roughly equally) found and only one (FC31) alone occurred among patient haplotypes. Nevertheless, the presence of several instances of the (FC31, DR7, DQ2) fragment suggests that the susceptibility gene on this haplotype, too, may be between the complotypes and DR regions. Although ethnic differences between DH and GSE patients might affect the extent of fragmentation of the relevant extended haplotypes (30, 31) , this would not in itself be expected to result in enrichment of some specific fragments over others.
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Dermatitis herpetiformis odds ratio p <0.002.
We believe that there are a number of susceptibility genes for DH and a number for GSE at a single locus for each disease acting in an essentially, but not simply, recessive manner. Others have found that DR4 haplotypes may contribute "minor" susceptibility to GSE (32) . From our results, the major susceptibility markers for GSE are DR3, DQ2 and DR7, DQ2, and the minor markers are DR4, DQ7; DR5, DQl ; DR2, DQ1 ; and DR6, DQ1 . We cannot, however, rule out 2 distinct MHC susceptibility loci (DQ and DP related) in GSE and three (complotype, DR/DQ, and DP related) in DH. Against the latter possibility is the presence primarily of (DR3, DQ2) and (DR7, DQ2) but not (FC31) or (SC01) in GSE and SCO1, rather than chiefly class II fragments in DH patient haplotypes. If both DQ and complotype genes were required for recessive expression, the minimum fragment should contain both complotype and DQ susceptibility genes.
The relatively greater diversity of HLA-A alleles on [HLA-B8, SCOT, DR3] haplotypes in GSE compared with the same haplotypes in DH patients or normals, in whom 75-80% of instances carry HLA-Al, may reflect the susceptibility gene localization results. Since there was enrichment for DR, DQ fragments in GSE, one might expect less homogeneity of 2073 Ahmed et al.
Gluten-sensitive enteropathy odds ratio the HLA-A region which is 2 x 106 base pairs telomeric to the class II region . It follows that if the susceptibility locus is near the complotype region, perhaps between the latter and DR, DQ, this may result in the observed higher HLAAl frequency on [HLA-138, SCO1, DR3] in DH than in GSE . Recent studies have raised the possibility ofspecific HLA-DP alleles being associated with GSE (33) (34) (35) and DH (36) . Our finding of an increase in the frequency of a specific DP allele, DPB1"0101, in both our GSE and DH patients over normal controls supports this possibility. We did not find increases in DPB1"04 and DPBl"03 alleles in GSE, as reported by Bugawan et al. (34) , nor the increase in DP3 found by Kagnoff et al. (35) , but confirmed the increase in DPl found by this group. We found DPBl*0101 to be increased, particularly in association with HLA-DR3, suggesting that the [HLA-138, SCOT, DR3] extended haplotype often extends through DP in both GSE (34) and DH (9, 36, 37) patients as well as in normals (10) . In this view, the increase in the DP marker may be because of known linkage disequilibrium between [HLA-138, SCOT, DR3] and DP1 (10, 11) (DPBl"0101) but may also reflect the possibility that the DP region contains a susceptibility gene (33 
